节点文献

血液病患者PICC导管相关性静脉血栓风险评估体系研制

Development of Risk Assessment System of PICC Catheter-Associated Venous Thrombus in Patients with Hematological Diseases

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 邵帅苏醒杨苗苗庄淑梅张慧敏

【Author】 SHAO Shuai;SU Xing;YANG Miaomiao;State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Hematology & Blood Diseases Hospital,CAMS & PUMC;

【通讯作者】 张慧敏;

【机构】 中国医学科学院血液病医院(中国医学科学院血液学研究所)/实验血液学国家重点实验室/国家血液系统疾病临床医学研究中心/细胞生态海河实验室/天津医学健康研究院天津医科大学护理学院

【摘要】 目的 构建血液病患者PICC导管相关性静脉血栓(PICC-RVT)风险评估体系。方法 检索PICC-RVT相关文献,建立初始指标池;通过小组讨论,初步拟定血液病患者PICC-RVT风险评估指标;采用德尔菲法进行两轮专家函询,利用层次分析法确定指标权重。结果 两轮函询专家积极程度分别为100%、88.0%,专家权威系数分别为0.831、0.925,Kendall’s W系数分别为0.227、0.364。最终形成的血液病患者PICC-RVT风险评估体系包含一级指标4个、二级指标13个、三级指标43个。结论 构建的血液病患者PICC-RVT风险评估体系具有一定科学性,为评估血液病患者PICC-RVT风险提供了工具。患者、治疗、导管以及操作是血液病患者PICC-RVT风险评估需重点关注的内容。

【Abstract】 Objective To develop a risk assessment system for Peripherally Inserted Central Catheter Related Venous Thrombus(PICC-RVT) in patients with hematological diseases. Methods PICC-RVT related literature was retrieved and initial index pool was established. Through group discussion, the PICC-RVT risk assessment indexes of patients with hematological diseases were preliminarily developed. Two rounds of expert correspondence were conducted by Delphi method, and the index weights were determined by analytic hierarchy process. Results The positive degree of the two rounds of correspondence consultation with experts was 100% and 88.0%, the expert authority coefficient was 0.831 and 0.925, and the Kendall’s W coefficient was 0.227 and 0.364, respectively. The final PICC-RVT risk assessment system for patients with hematological diseases contains 4 first-level indicators, 13 second-level indicators and 43 third-level indicators. Conclusion The established PICC-RVT risk assessment system for patients with hematologic diseases is scientific and provides a tool for assessing the risk of PICC-RVT in patients with hematologic diseases. Patients, treatments, catheters, and procedures are key aspects of PICC-RVT risk assessment in patients with hematologic diseases.

【基金】 中国医学科学院医学与健康科技创新工程项目资助(编号:2021-I2M-C&T-B-085)
  • 【文献出处】 中国卫生质量管理 ,Chinese Health Quality Management , 编辑部邮箱 ,2024年02期
  • 【分类号】R473.5
  • 【下载频次】31
节点文献中: 

本文链接的文献网络图示:

本文的引文网络